These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 8170422

  • 1. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ, Robertson PW, Whybin LR.
    Med J Aust; 1994 Apr 18; 160(8):478-82. PubMed ID: 8170422
    [Abstract] [Full Text] [Related]

  • 2. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B.
    Am J Infect Control; 2006 Nov 18; 34(9):583-7. PubMed ID: 17097453
    [Abstract] [Full Text] [Related]

  • 3. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M.
    J Infect Public Health; 2012 Apr 18; 5(2):127-32. PubMed ID: 22541258
    [Abstract] [Full Text] [Related]

  • 4. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 18; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 5. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM, Flowers CA, Congdon CL.
    Obstet Gynecol; 2005 Aug 18; 106(2):295-300. PubMed ID: 16055578
    [Abstract] [Full Text] [Related]

  • 6. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P, Amstad H, Grize L, Gassner M, Takken-Sahli K, Bourquin C, Braun-Fahrländer C.
    Praxis (Bern 1994); 1999 Jun 10; 88(24):1069-77. PubMed ID: 10420798
    [Abstract] [Full Text] [Related]

  • 7. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E, Tischer A.
    Gesundheitswesen; 1993 Jan 10; 55(1):38-9. PubMed ID: 8435543
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M, Christenson B, Strandell A, Romanus V.
    Dev Biol Stand; 1986 Jan 10; 65():37-43. PubMed ID: 3556776
    [Abstract] [Full Text] [Related]

  • 9. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986 Jan 10; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 10. Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy.
    Stover BH, Adams G, Kuebler CA, Cost KM, Rabalais GP.
    Infect Control Hosp Epidemiol; 1994 Jan 10; 15(1):18-21. PubMed ID: 8133004
    [Abstract] [Full Text] [Related]

  • 11. Healthcare workers and immunity to infectious diseases.
    Vagholkar S, Ng J, Chan RC, Bunker JM, Zwar NA.
    Aust N Z J Public Health; 2008 Aug 10; 32(4):367-71. PubMed ID: 18782402
    [Abstract] [Full Text] [Related]

  • 12. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.
    Przegl Epidemiol; 2003 Aug 10; 57(2):281-8. PubMed ID: 12910596
    [Abstract] [Full Text] [Related]

  • 13. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC, Burgess MA, O'Brien ED.
    Commun Dis Intell; 1998 Aug 06; 22(8):159. PubMed ID: 9735551
    [No Abstract] [Full Text] [Related]

  • 14. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 15. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ, Orenstein WA, Hinman AR.
    Dev Biol Stand; 1986 May 31; 65():45-52. PubMed ID: 3104117
    [Abstract] [Full Text] [Related]

  • 16. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J, da Cunha S, Côrte-Real R, Sampaio L, Dais N, Meliço-Silvestre A.
    Acta Med Port; 1995 Apr 31; 8(4):206-16. PubMed ID: 7625214
    [Abstract] [Full Text] [Related]

  • 17. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í, Köse Ş, Akbulut Í, Albayrak H.
    Rev Esp Quimioter; 2019 Dec 31; 32(6):525-531. PubMed ID: 31642641
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
    Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S.
    Infect Control Hosp Epidemiol; 2004 Jul 31; 25(7):591-4. PubMed ID: 15301032
    [Abstract] [Full Text] [Related]

  • 19. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J, Dias N, Ferreira TM, da Cunha S, Costa D, Côrte-Real R, Meliço-Silvestre A.
    Acta Med Port; 1999 Jul 31; 12(4-6):155-60. PubMed ID: 10481316
    [Abstract] [Full Text] [Related]

  • 20. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P.
    Ann Ig; 1998 Jul 31; 10(1):19-24. PubMed ID: 9616974
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.